Edwards Lifesciences: Edwards Hit With $10M Penalty Over JC Medical Deal
Edwards Lifesciences Corp. agreed to pay $10 million in penalties linked to its 2024 acquisition of JC Medical, former subsidiary of Singapore-based Genesis MedTech. The Federal Trade Commission's complaint alleges that Edwards and Genesis intentionally structured the deal to avoid federal premerger filing requirements. Genesis will also pay a $2 million penalty under the terms [...]
Read full article »
Edwards is a California-based medical device firm that develops and supplies products such as transcatheter heart valves and pressure transducers for the healthcare industry.
Read more